Obesity is now recognised as a chronic disease that is complex and multifactorial. This means it is influenced by a variety of factors including genetics, environment, metabolism, and behavior. At LMC, we offer holistic weight management programs that integrate medical and health coaching aspects to provide a well-rounded approach to weight loss and management.
At LMC, we aim to help you lose weight through clinically proven and sustainable weight loss solutions. This means losing weight at a healthy and steady pace, and teaching you valuable information about health and nutrition.
Our weight loss programme includes:
Health coaching for sustainable and effective lifestyle changes in your food, physical activity and sleep to aid in weight loss and prevent weight gain.
Nutritional consultation for dietary advice to ensure balanced nutritional intake for healthy weight loss
Medical evaluation for underlying medical conditions and weight related complications
Treatment with medications to aid in weight loss if suitable
Our medical team will evaluate to see if there are any underlying medical conditions that make it hard for you to lose weight (e.g. thyroid disorders) We also assess for health-related complications that can arise from obesity.
In some cases, medications such as weight loss injection pens may be necessary to assist with weight loss. These medications may have different efficacies in different individuals. One example of a weight loss injection pen is liraglutide, a hormone glucagon-like peptide-1 (GLP-1) which regulates appetite by acting on the brain to reduce hunger and increase feelings of fullness. This helps decrease overall calorie intake, contributing to weight loss.
Liraglutide, also known as Saxenda, has been studied in multiple peer-reviewed journals regarding its effectiveness. In one particular research published in 2017, 3731 individuals were monitored for 56 weeks. The patients had a BMI of 30 or higher without diabetes, or a BMI of 27 or higher with at least one weight-related medical condition. They were divided into two groups of patients–one was treated with Saxenda, and the other a placebo. Both groups were told to control their diet and engage in exercise. At the end, one out of every three individuals who used Saxenda lost more than 10% of their body weight. Patients who completed the study and lost weight with Saxenda lost an average of 9.2% of their body weight and kept it off for a year. Patients’ cardiometabolic risk factors also improved in a number of ways.
In Singapore, weight loss injections are recommended for individuals with higher risk of obesity-related health issues: